Poland· PL-100424790
LysaKare
A arginin und lysin product containing l-lysini hydrochloridum + l-arginini hydrochloridum, registered in Poland by Advanced Accelerator Applications. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Arginin und lysin is registered in 8 of 19 countries.
Countries holding a registration under ATC V03AF11 (arginin und lysin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Arginin und lysin · ATC V03AF11
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- L-Lysini hydrochloridum + L-Arginini hydrochloridum
- Manufacturer
- Advanced Accelerator Applications
- Country
- Poland (PL)
- ATC code
- V03AF11
- ATC class
- Arginin und Lysin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin03665808000033
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Arginin und lysin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomArginine 25g/1litre / Lysine 25g/1litre infusion bagsSpecial Order
- SpainLYSAKARE 25 G/25 G SOLUCION PARA PERFUSIONNovartis Europharm Limited
- FinlandLysakareNovartis Europharm Limited
- FranceLYSAKARE 25 g/25 g, solution pour perfusionNOVARTIS EUROPHARM (IRLANDE)
- IrelandLysaKare 25 g/25 g Solution for infusionNovartis Europharm Limited
- IcelandLysaKareNovartis Europharm Limited*
- CzechiaLYSAKARENovartis Europharm Limited, Dublin
- SwedenLysaKare 25 mg / 25 mg Infusionsvätska, lösningNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Lysakare
- Liechtenstein · Lysakare
- Norway · Lysakare
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e6983283-87fb-44ac-934d-1bfa3d67e460 GET /v1/drugs/e6983283-87fb-44ac-934d-1bfa3d67e460?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do infuzji",
"source": "urpl",
"strength": "(25 mg + 25 mg)/ml",
"packaging": "Rpz ¦ EU/1/19/1381/001 ¦ 134047\n1 worek 1000 ml\n¦ UR/Z/4c/109/24 - 03665808000033 ¦ UR/Z/4c/175/23 - 03665808000033 ¦ UR/Z/4c/014/25 - 03665808000033 ¦ UR/Z/4c/022/23 - 03665808000033 ¦ UR/Z/4c/118/25 - 03665808000033 ¦ UR/Z/4c/202/25 - 03665808000033 ¦ UR/Z/4c/304/25 - 03665808000033 ¦ UR/Z/4c/208/26",
"substance": "L-Lysini hydrochloridum 25 mg/ml + L-Arginini hydrochloridum 25 mg/ml",
"common_name": "L-Lysini hydrochloridum + L-Arginini hydrochloridum",
"pl_product_id": "100424790",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about arginin und lysin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.